Some people who study companies and their values, called analysts, changed their opinions on a company named Eastman Chemical after it told everyone how much money it made in the first three months of this year. They said the company is worth more or less than before. Some of them think it's a good idea to buy shares of the company because they believe it will make even more money in the future, while others are not so sure and just think it's okay to keep the same value as before. This information can help people decide if they want to invest their money in this company or not. Read from source...

- The title of the article is misleading and does not reflect the actual content. It implies that there were multiple analysts who revised their forecasts on Eastman Chemical after Q1 earnings, but in reality, only two analysts are mentioned: B of A Securities and Jefferies.
- The article contains outdated information, as it mentions the price target cut by B of A Securities on Friday, which is already four days ago. This suggests that the article is not up to date with the latest developments in the stock market.
- The article does not provide any context or explanation for why these analysts revised their forecasts. It simply states the new price targets and ratings without any analysis of the factors behind them, such as earnings growth, sales performance, industry trends, etc. This makes the article incomplete and unsatisfying for readers who want to understand the rationale behind the changes in the analysts' views.
- The article includes a section that promotes Benzinga's services and features, which is irrelevant and unprofessional. It detracts from the credibility of the article and appears as an attempt to advertise and attract users to sign up for Benzinga's platforms. This also creates a potential conflict of interest, as it may influence the author's choice of sources and selection of information.
- The article lacks any critical evaluation or comparison of the analysts' forecasts and recommendations. It simply reports what they said without questioning their accuracy, reliability, or validity. This makes the article one-sided and uninformative, as it does not provide any insights or perspectives that could help readers make better investment decisions.

1. B of A Securities: Buy rating with a reduced price target from $113 to $112, implying a 0.9% upside potential based on Friday's closing price of $112.56. Risk factors include possible decline in earnings and revenues due to the COVID-19 pandemic, as well as increased competition and regulatory scrutiny in the chemical industry.